Detailed Selling Lead Description
Brand: YC
Model: Skype: tom131393
Price: USD 1 / g
Min. Order: 10 g g
Regorafenib CAS:755037-03-7
Product Name: Regorafenib
CAS: 755037-03-7
MF: C21H15ClF4N4O3
MW: 482.8154128
Product Categories: Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Anti-cancer&immunity
Usage:
1.It inhibits PDGFR tyrosine kinase with IC50=83nM. It is useful for the treatment of inflammation and as an anti-proliferative agent.
2.BAY 73-4506 (Regorafenib) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf.
3.Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively
Related VEGFR Products :
Vandetanib (ZD6474) CAS: 443913-73-3
Cabozantinib (XL184, BMS-907351) CAS: 849217-68-1
Axitinib CAS: 319460-85-0
Nintedanib (BIBF 1120) CAS: 656247-17-5
SU5402 CAS: 215543-92-3
Erlotinib CAS: 183321-74-6
R428 (BGB324) CAS: 1037624-75-1
Axitinib CAS: 319460-85-0
Vandetanib (ZD6474) CAS: 443913-73-3
Lenvatinib (E7080) CAS: 417716-92-8
Pazopanib CAS: 444731-52-6
Pazopanib HCl (GW786034 HCl) CAS: 635702-64-6
Crizotinib (PF-02341066) CAS: 877399-52-5
Sunitinib Malate CAS: 341031-54-7
Trametinib (GSK1120212) CAS: 871700-17-3
Ponatinib (AP24534) CAS: 943319-70-8
Dabrafenib (GSK2118436) CAS: 1195765-45-7